Diagnostic assessment and outcome of acute pancreatitis in Italy: Results of a prospective multicentre study: ProInf-AISP: Progetto informatizzato pancreatite acuta, Associazione Italiana Studio Pancreas, phase II

14 citazioni su Scopus. L'articolo è il risultato di uno studio multicentrico di cui G. Benassai è un autore (membro Proinf-Aisp Study Group). RE: Missing Author Name Scopus nlinfo@elsevier.com; Dear Prof. Giacomo Benassai, Thank you very much for your detailed explanation. You have made the issue perfectly clear to me. Please be informed that I have escalated the issue to our Content Department for investigation and they will rectify the issue accordingly. As soon as I receive an answer, I am happy to contact you back. If I, or one of my colleagues, can assist you with another matter please do let us know. Kind Regards, Jeroen Hulsmann E-Helpdesk EMEA Coordinator Regional Sales Office - EMEA Elsevier B.V. [THREAD ID:1-1J7YLX6] -----Original Message----- From: gbenassa@unina.it Sent: 12/09/2012 14:52:37 To: nlinfo@elsevier.com Subject: Re: FW: Author's name correction Distinct Mr. Hulsmann Thank you for the sollicit interest about my query.This question it's very important for my career evaluation and also for the University 's department in which i belong. I have participated as a researcher in the 3 papers reported in my previous email,all of them were multicentric,so as of definition they involve diverse Institutions and Authors.In the list of Authors reported,members of the ProINF-AISP study group are citated under the voice "the members of the ProInf-AISP Study Group" who obviously do not correspond to a single unit.The single members of the citated group,amongst them the writer,are citated singularly on the last page's appendix ("G. Mosella, G. Benassai Policlinico Universitario Federico II") Napoli. The non citation of this partecipation of the Naples University Federico II comes with a problem regarding the financiation of the department,and also a discrimination on the evaluation of my personal profile as a researcher about the calculation of the citations in the H index. Furthermore in other circumstances i was citated as a participant in group studies of multicenter works,such as "Imipenem/cilastatina (1,5gr/die) versus meropenem (3,0gr/die) in pazienti con infezioni intra-addominali:risultati di uno studio clinico multicentrico,randomizzato,prospettico" publicated on Scandinavian Journal of Infectious Diseases 29:503-508,1997.I believe you have an original PDF file of this work and not a copy,therefore i result citated on scopus as a participant of the group study "Gruppo di studio Italiano" Thank you for your courtesy and interest,given the importance of the query. Trustfully yours, Prof. Giacomo Benassai Elsevier B.V. Registered Office: Radarweg 29, 1043 NX Amsterdam, The Netherlands, Registration No. 33156677 (The Netherlands) http://www.ncbi.nlm.nih.gov/pubmed/17625994 http://www.scopus.com/record/display.url?eid=2-s2.0-34547681809&origin=resultslist&sort=plf-f&src=s&st1=diagnostic+assessment+and+outcome+of+acute+pancreatitis+in+Italy&sid=oNVoDQG_UHipYnJz9G131SP%3a730&sot=q&sdt=b&sl=84&s=TITLE-ABS-KEY-AUTH%28diagnostic+assessment+and+outcome+of+acute+pancreatitis+in+Italy%29&relpos=2&relpos=2&searchTerm=TITLE-ABS-KEY-AUTH(diagnostic assessment and outcome of acute pancreatitis in Italy) BACKGROUND AND AIM: Up till now, only one study providing practically complete information on acute pancreatitis in Italy has been published. The aim of this prospective study was to evaluate the clinical characteristics, in terms of diagnostic assessment and outcome, of a large series of patients affected by acute pancreatitis in Italy. MATERIALS AND METHODS: The study involved 56 Italian centres, homogeneously distributed throughout the entire national territory. Each participating centre was furnished with an ad hoc software including 530 items along with subsequent collection, tabulation and quality control of the data. RESULTS: One thousand five hundred and forty case report forms of patients affected by acute pancreatitis were collected but 367 of them (24%) were subsequently eliminated from the final analysis. Therefore, 1173 patients (581 females and 592 males) were recruited. Mean age of patients was 62.0+/-18.2 years (95% confidence interval, 60.9-63.0). On the basis of Atlanta classification, 1006 patients (85.8%) were defined as mild and 167 (14.2%) as severe pancreatitis. Biliary forms represented the most frequent aetiological category (813 cases, 69.3%) while alcoholic forms only 6.6% (77 cases); the remaining aetiologies accounted for 7.1% (83 cases) while 200 cases (17.1%) remained without a definite aetiological factor. Complete recovery was achieved in 1016 patients (86.6%) whereas morphological sequelae were found in 121 patients (10.3%) and mortality in 36 patients (3.1%; 0.4% in mild and 19.2% in severe acute pancreatitis). Ultrasonography was largely utilised as a first line diagnostic tool in all patients, with valuable visualisation of the pancreas in 85% of patients. Computer tomography scan was also widely used, with 66.7% of exams in mild and 33.3% in severe pancreatitis. Patients affected by biliary pancreatitis presented more severe (p=0.004) and necrotizing forms (p=0.021). Mortality was significantly related (p<0.001) with the extension of pancreatic necrosis and with an age of over 70 years. Body mass index presented significantly greater values in severe than in mild forms (p<0.001). CONCLUSIONS: Association of creatinine serum level over 2mg/dl with an abnormal chest X-ray showed a high significant correlation with a more severe outcome in terms of morphological sequelae and mortality (p=0.0001). Acute pancreatitis in Italy more commonly presents biliary aetiology and favourable outcome with low rate of complications and mortality. From a cost-effectiveness standpoint, diagnostic approach to this disease needs to be better standardised.